MABVAX THERAPEUTICS HOLDINGS, INC. (NASDAQ:MBVX) Files An 8-K Other EventsItem 8.01 Other Events.
On November 16 2017, MabVax Therapeutics Holdings, Inc. (the “Company”) issued a press release announcing that the Company has regained compliance with the NASDAQ Capital Market’s minimum stockholders’ equity listing requirements. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits. Exhibit
|
Exhibit No. |
Description |
|
Press release announcing that the Company regained compliance with the NASDAQ Capital Market’s stockholders’ equity requirement, issued on November 16, 2017 |
MABVAX THERAPEUTICS HOLDINGS, INC. ExhibitEX-99.1 2 ex99-1.htm PRESS RELEASE Blueprint Exhibit 99.1 MabVax Therapeutics Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Listing Requirements SAN DIEGO (November 16,…To view the full exhibit click here